Advertisement

Clinical Pharmacokinetics

, Volume 58, Issue 7, pp 979–980 | Cite as

Author’s Reply to Trechot: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

  • Didier Concordet
  • Peggy Gandia
  • Jean-Louis Montastruc
  • Alain Bousquet-Mélou
  • Peter Lees
  • Aude A. Ferran
  • Pierre-Louis ToutainEmail author
Letter to the Editor
  • 20 Downloads

Notes

Compliance with Ethical Standards

Funding

No sources of funding were used in the preparation of this reply.

Conflict of interest

Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, and Pierre-Louis Toutain declare no relevant potential conflicts of interest.

References

  1. 1.
    Trechot P. Comment on “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”. Clin Pharmacokinet. 2019.  https://doi.org/10.1007/s40262-019-00784-y.Google Scholar
  2. 2.
    Concordet D, Gandia P, Montastruc J-L, Bousquet-Mélou A, Lees P, Ferran A, et al. Levothyrox® new and old formulations: are they switchable for millions of patients? Clin Pharmacokinet. 2019.  https://doi.org/10.1007/s40262-019-00747-3 (epub 4 Apr 2019).Google Scholar
  3. 3.
    Aronson JK, La Caze A, Kelly MP, Parkkinen V-P, Williamson J. The use of mechanistic evidence in drug approval. J Eval Clin Pract. 2018;24:1166–76.CrossRefGoogle Scholar
  4. 4.
    Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58:265–78.CrossRefGoogle Scholar
  5. 5.
    Chen M-L, Sadrieh N, Yu L. Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs. AAPS J. 2013;15:1043–50.CrossRefGoogle Scholar
  6. 6.
    Shah HS, Chaturvedi K, Hamad M, Bates S, Hussain A, Morris K. New insights on solid-state changes in the levothyroxine sodium pentahydrate during dehydration and its relationship to chemical instability. AAPS PharmSciTech. 2019;20:39.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.INTHERES, Université de Toulouse, INRA, ENVTToulouseFrance
  2. 2.Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Centre Hospitalier Universitaire de ToulouseUniversité de ToulouseToulouseFrance
  3. 3.The Royal Veterinary CollegeUniversity of LondonLondonUK

Personalised recommendations